Telemonitoring with Healthdot in a surgical ward

SWITCH- Surgical Ward Innovation: Telemonitoring Controlled by Healthdot Evaluation of Implementation

This study is testing if using a smart monitoring device called Healthdot can improve care for patients in a surgical ward at a hospital in the Netherlands.

Quick facts

• Study type: Observational
• Enrollment: 500 (estimated)
• Ages: 18 Years and up
• Sex: All
• Sponsor: Catharina Ziekenhuis Eindhoven (Academic / other)
• Locations: 1 site (Eindhoven, Noord-Brabant)
• Trial ID: NCT05956210 on ClinicalTrials.gov

What this trial studies

This observational study evaluates the implementation of the Philips Healthdot smart monitoring device in a surgical ward at Catharina hospital in Eindhoven, Netherlands. Over a six-month period, all patients admitted to the ward will receive a Healthdot, transitioning from traditional manual monitoring to smart monitoring in a phased approach. The first three months will focus on training staff and optimizing the use of the device, while the latter three months will primarily utilize Healthdot for monitoring. The study aims to assess the effectiveness and integration of this technology into standard care practices.

Who should consider this trial

Good fit: Ideal candidates for this study are patients admitted to the surgical ward at Catharina hospital during the study period.

Not a fit: Patients who are not admitted to the surgical ward or those who do not consent to the use of their anonymized data may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could enhance patient monitoring and improve outcomes in surgical wards.

How similar studies have performed: While the use of telemonitoring devices is gaining traction, this specific implementation of Healthdot in a surgical setting is relatively novel.

Eligibility criteria

Nurses and physicians form the primary research population.

- Nurses and physicians, participating in het focus group will sign informed consent.

Patients won't be included for participation since the Healthdot will be the new standard of care regarding monitoring. Patients will however sign informed consent at admission for use of anonymized data.

Inclusion Criteria:

Nurses

* Registered in the national register of medical professions (Big register)
* Appointed as a nurse at the Catharina hospital and working at the surgical department during the study period
* Willingness to participate in the core group for evaluation of the implementation

Physicians

* Registered in the national register of medical professions (Big register)
* Appointed at the Catharina hospital as a physician or resident during the study period.
* Willingness to participate in the core group for evaluation of the implementation

Exclusion Criteria:

Nurses \& Physicians

* Termination of employment within the study period
* No voluntarily participation in the core group evaluation meetings

Contra-indications for applying Healthdot

* Known to have severe allergy for the tissue adhesive used in the Healthdot.
* Any skin condition, for example prior severe rash, discoloration, scars or open wounds at the area of application
* Pregnant, or breastfeeding
* Use of topicals that are known to irritate the skin at the application area (such as medical and non-medical creams or lotions)
* Patient with active implantable device such as a Implantable Cardiac Defibrillator (ICD) or pacemaker
* Unable to understand instructions
* Left lower rib (place where Healthdot will be applied) is involved in the area of surgery, area of disinfection or area where bandages are needed.
* Transfer to a different ward during hospitalization

Where this trial is running

Eindhoven, Noord-Brabant

• Catharina hospital — Eindhoven, Noord-Brabant, Netherlands (Recruiting)

Study contacts

• Principal investigator: Friso Schonck — Catharina Ziekenhuis Eindhoven
• Study coordinator: Friso Schonck

Conditions Monitoring